Key statistics
As of last trade, Abeona Therapeutics Inc (ABEO:NAQ) traded at 5.87, 92.46% above the 52 week low of 3.05 set on Apr 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.81 |
---|---|
High | 5.93 |
Low | 5.72 |
Bid | 5.85 |
Offer | 5.87 |
Previous close | 5.80 |
Average volume | 178.52k |
---|---|
Shares outstanding | 43.31m |
Free float | 41.12m |
P/E (TTM) | -- |
Market cap | 251.22m USD |
EPS (TTM) | -2.13 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 18:34 BST.
More ▼
- Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors
- Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel
- Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission
- Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications
- Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum
- Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
- Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
More ▼